Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes

Finerenone is a selective nonsteroidal mineralocorticoid receptor antagonist with a short half-life. Its effects on cardiorenal outcomes were thought to be mediated primarily via nonhemodynamic pathways, but office blood pressure (BP) measurements were insufficient to fully assess hemodynamic effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Rajiv, Ruilope, Luis M., Ruiz-Hurtado, Gema, Haller, Hermann, Schmieder, Roland E., Anker, Stefan D., Filippatos, Gerasimos, Pitt, Bertram, Rossing, Peter, Lambelet, Marc, Nowack, Christina, Kolkhof, Peter, Joseph, Amer, Bakris, George L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799031/
https://www.ncbi.nlm.nih.gov/pubmed/36583355
http://dx.doi.org/10.1097/HJH.0000000000003330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9799031/
https://www.ncbi.nlm.nih.gov/pubmed/36583355
http://dx.doi.org/10.1097/HJH.0000000000003330

Ejemplares similares